Page 3 - Statistical Analysis Plan News Today

In the Phase IIb NATIVE, lanifibranor met both the primary and key secondary endpoints, including NASH resolution with no worsening of fibrosis and improvement of liver fibrosis with no worsening of NASHNATIVE

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

In a pilot randomised controlled trial, Simon Gilbody and colleagues present preliminary findings from a telephone delivered intervention (behavioural activation) designed to prevent depression and loneliness among socially isolated older people with long term conditions.

Toronto, ON (PRWEB) May 25, 2021 -- Clinical development has more partnerships and collaborations than ever before with many companies acquiring assets from

Search jobs 24-May-2021 Abivax reports excellent efficacy and safety of ABX464 in phase 2b clinical trial in ulcerative colitis and plans to proceed to phase 3 DGAP-News: ABIVAX / Key word(s): Study results 24.05.2021 / 18:30 The issuer is solely responsible for the content of this announcement. Abivax reports excellent efficacy and safety of ABX464 in phase 2b clinical trial in ulcerative colitis and plans to proceed to phase 3 Primary endpoint ...

In September 2020, Acasti engaged Oppenheimer & Company Inc to act as its financial advisor to assist in the review aimed at enhancing shareholder value

Biostatisticians draft blueprints for COVID-19 vax trials Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic February 18, 2021 • By Sabin Russell / Fred Hutch News Service Dr. Peter Gilbert (left) leads a team of Fred Hutch biostatisticians that pivoted to COVID-19 vaccine trial design. Dr. Holly Janes (right) is a co-principal investigator with Gilbert at the Statistical and D...